MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells.

Abstract:

:Milk fat globule-EGF factor 8 (MFG-E8) is a glycoprotein highly expressed in breast cancer that contributes to tumor progression through largely undefined mechanisms. By analyzing publicly available gene expression profiles of breast carcinomas, we found that MFG-E8 is highly expressed in primary and metastatic breast carcinomas, associated with absent estrogen receptor expression. Immunohistochemistry analysis of breast cancer biopsies revealed that MFG-E8 is expressed on the cell membrane as well as in the cytoplasm and nucleus. We also show that increased expression of MFG-E8 in mammary carcinoma cells increases their tumorigenicity in immunodeficient mice, and conversely, its downregulation reduces their in vivo growth. Moreover, expression of MFG-E8 in immortalized mammary epithelial cells promotes their growth and branching in three-dimensional collagen matrices and induces the expression of cyclins D1/D3 and N-cadherin. A mutant protein unable to bind integrins can in part exert these effects, indicating that MFG-E8 function is only partially dependent on integrin activation. We conclude that MFG-E8-dependent signaling stimulates cell proliferation and the acquisition of mesenchymal properties and contributes to mammary carcinoma development.

journal_name

Oncogene

journal_title

Oncogene

authors

Carrascosa C,Obula RG,Missiaglia E,Lehr HA,Delorenzi M,Frattini M,Rüegg C,Mariotti A

doi

10.1038/onc.2011.356

subject

Has Abstract

pub_date

2012-03-22 00:00:00

pages

1521-32

issue

12

eissn

0950-9232

issn

1476-5594

pii

onc2011356

journal_volume

31

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Frequent loss of heterozygosity on chromosomes 7 and 9 in benign epithelial ovarian tumours.

    abstract::It is presently unclear if ovarian cancers arise through malignant transformation of pre-existing benign tumours. The apparent rarity of loss of heterozygosity (LOH) reported for benign tumours has led to speculation that they lack malignant potential and represent a biological entity distinct from ovarian carcinoma. ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201372

    authors: Roy WJ Jr,Watson RH,Hitchcock A,Campbell IG

    更新日期:1997-10-23 00:00:00

  • Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.

    abstract::E mu-bcl-2 transgenic mice bearing the bcl-2 proto-oncogene linked to the immunoglobulin enhancer (E mu) sporadically develop B or T cell lymphomas after a long latent period. To identify genes that play important roles in development of lymphoid malignancies, proviral insertional mutagenesis with Moloney murine leuke...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Shinto Y,Morimoto M,Katsumata M,Uchida A,Aozasa K,Okamoto M,Kurosawa T,Ochi T,Greene MI,Tsujimoto Y

    更新日期:1995-11-02 00:00:00

  • PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation.

    abstract::PI3K/AKT pathway activation is thought to be a driving force in metastatic melanomas. Members of the pleckstrin homology (PH) domain leucine-rich repeat protein Ser/Thr specific phosphatase family (PHLPP1 and PHLPP2) can regulate AKT activation. By dephosphorylating specific serine residues in the hydrophobic motif, P...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0061-7

    authors: Yu Y,Dai M,Lu A,Yu E,Merlino G

    更新日期:2018-04-01 00:00:00

  • Medullary thyroid carcinomas in transgenic mice expressing a Polyoma carboxyl-terminal truncated middle-T and wild type small-T antigens.

    abstract::Medullary thyroid carcinoma (MTC) is a rare human tumor affecting the calcitonin-secreting c-cells of the thyroid. Here we report that two independent strains of transgenic mice expressing a Polyomavirus (Py) truncated middle-T antigen (deltaMT), consisting of the amino-terminal 304 amino acids, and the full length Py...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202578

    authors: Felici A,Giorgio M,Krauzewicz N,Della Rocca C,Santoro M,Rovere P,Manni I,Amati P,Pozzi L

    更新日期:1999-04-08 00:00:00

  • Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis.

    abstract::Familial adenomatous polyposis (FAP) is caused by germline mutations in the adenomatous polyposis coli (APC) gene. Two promoters, 1A and 1B, have been recognized in APC, and 1B is thought to have a minor role in the regulation of the gene. We have identified a novel deletion encompassing half of this promoter in the l...

    journal_title:Oncogene

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1038/onc.2011.201

    authors: Rohlin A,Engwall Y,Fritzell K,Göransson K,Bergsten A,Einbeigi Z,Nilbert M,Karlsson P,Björk J,Nordling M

    更新日期:2011-12-15 00:00:00

  • Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease.

    abstract::Degradation of cellular proteins through ubiquitination is a fundamental strategy for regulating biological pathways. De-ubiquitination, i.e. the removal of ubiquitin from proteins and peptides to which ubiquitin is attached, is catalyzed by processing proteases known as de-ubiquitinating enzymes. We are studying the ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204553

    authors: Soncini C,Berdo I,Draetta G

    更新日期:2001-06-28 00:00:00

  • Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.

    abstract::Ataxia-Telangiectasia (A-T) is an autosomal recessive human disease characterized by genetic instability, radiosensitivity, immunodeficiency and cancer predisposition, because of mutation in both alleles of the ATM (ataxia-telangiectasia mutated) gene. The role of Atm heterozygosity in cancer susceptibility is controv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.280

    authors: Mao JH,Wu D,DelRosario R,Castellanos A,Balmain A,Perez-Losada J

    更新日期:2008-11-20 00:00:00

  • Cytokine receptors and hematopoietic differentiation.

    abstract::Colony-stimulating factors and other cytokines signal via their cognate receptors to regulate hematopoiesis. In many developmental systems, inductive signalling determines cell fate and, by analogy with this, it has been postulated that cytokines, signalling via their cognate receptors, may play an instructive role in...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210756

    authors: Robb L

    更新日期:2007-10-15 00:00:00

  • CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.

    abstract::Casitas B-lineage lymphoma (CBL) protein family functions as multifunctional adaptor proteins and E3 ubiquitin ligases that are implicated as regulators of signaling in various cell types. Recent discovery revealed mutations of proto-oncogenic CBL in the linker region and RING finger domain in human acute myeloid neop...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.18

    authors: Kang JM,Park S,Kim SJ,Hong HY,Jeong J,Kim HS,Kim SJ

    更新日期:2012-12-13 00:00:00

  • Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells.

    abstract::Treatment of quiescent Balb/3T3 clone A31-1-1 cells with 0.1-0.2 mM H2O2 in the presence of 1 microM insulin induced DNA synthesis 20-24 h later at almost the same level as that in cells treated with 10% serum. Treatment with 0.1-0.2 mM H2O2 alone did not induce DNA synthesis and was not toxic to the cells. Cell cycle...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Shibanuma M,Kuroki T,Nose K

    更新日期:1990-07-01 00:00:00

  • Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.

    abstract::Mxi1 is a basic region helix-loop-helix leucine zipper (bHLH/LZ) protein that, in association with Max, antagonizes Myc oncogenic activities. A possible mechanistic basis for Mxi1-mediated repression was provided by the recent demonstration that the repressive potential of Mxi1 correlates with its ability to physicall...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Rao G,Alland L,Guida P,Schreiber-Agus N,Chen K,Chin L,Rochelle JM,Seldin MF,Skoultchi AI,DePinho RA

    更新日期:1996-03-07 00:00:00

  • Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.

    abstract::Ras oncogenes (Hras, Kras and Nras) are important drivers of carcinogenesis. However, tumors with Ras mutations often show loss of the corresponding wild-type (WT) allele, suggesting that proto-oncogenic forms of Ras can function as a suppressor of carcinogenesis. In vitro studies also suggest that WT Ras proteins can...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.404

    authors: To MD,Rosario RD,Westcott PM,Banta KL,Balmain A

    更新日期:2013-08-22 00:00:00

  • And-1 is required for the stability of histone acetyltransferase Gcn5.

    abstract::Histone acetyltransferases (HATs) have a central role in the modification of chromatin as well as in the pathogenesis of a broad set of diseases including cancers. Gcn5 is the first identified transcription-related HAT that has been implicated in the regulation of diverse cellular functions. However, how Gcn5 proteins...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.261

    authors: Li Y,Jaramillo-Lambert AN,Yang Y,Williams R,Lee NH,Zhu W

    更新日期:2012-02-02 00:00:00

  • Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours.

    abstract::The p53 and MDM2 genes are part of a physiological pathway frequently impaired in human cancer. With the exception of tumours occasionally associated with hereditary predisposition, childhood malignancies have not been studied in detail yet. This is the first report on the analysis of p53 and MDM2 in a group of non-he...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kovar H,Auinger A,Jug G,Aryee D,Zoubek A,Salzer-Kuntschik M,Gadner H

    更新日期:1993-10-01 00:00:00

  • PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells.

    abstract::Oncoprotein C-MYC is overexpressed in human metastatic melanomas and melanoma-derived cells where it is required for the suppression of oncogene-induced senescence (OIS). The genetic events that maintain high levels of C-MYC in melanoma cells and their role in OIS are unknown. Here we report that C-MYC in cells from s...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.339

    authors: Mannava S,Omilian AR,Wawrzyniak JA,Fink EE,Zhuang D,Miecznikowski JC,Marshall JR,Soengas MS,Sears RC,Morrison CD,Nikiforov MA

    更新日期:2012-03-22 00:00:00

  • Poly(ADP-ribosyl)ation of p53 induces gene-specific transcriptional repression of MTA1.

    abstract::The metastasis-associated protein 1 (MTA1) is overexpressed in various human cancers and is closely connected with aggressive phenotypes; however, little is known about the transcriptional regulation of the MTA1 gene. This study identified the MTA1 gene as a target of p53-mediated transrepression. The MTA1 promoter co...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.2

    authors: Lee MH,Na H,Kim EJ,Lee HW,Lee MO

    更新日期:2012-12-06 00:00:00

  • THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.

    abstract::Promyelocytic leukemia (PML) nuclear bodies (PML NBs) are discrete subnuclear domains organized by the promyelocytic leukemia protein PML, a tumor suppressor essential for multiple apoptotic pathways. We have recently described a novel family of cellular factors, the THAP proteins, characterized by the presence at the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206271

    authors: Roussigne M,Cayrol C,Clouaire T,Amalric F,Girard JP

    更新日期:2003-04-24 00:00:00

  • The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A.

    abstract::A yeast two-hybrid screen has identified HBP1 as a transcription factor capable of interacting with the pocket protein family. We show that HBP1 can interact with one of these, RB, both in vitro and in mammalian cells. Two distinct RB binding sites are present within HBP1--a high affinity binding site, mediated by an ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201243

    authors: Lavender P,Vandel L,Bannister AJ,Kouzarides T

    更新日期:1997-06-05 00:00:00

  • Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains.

    abstract::Fusion proteins involving the BRAF serine/threonine kinase occur in many cancers. The oncogenic potential of BRAF fusions has been attributed to the loss of critical N-terminal domains that mediate BRAF autoinhibition. We used whole-exome and RNA sequencing in a patient with glioblastoma multiforme to identify a rearr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-1021-1

    authors: Weinberg F,Griffin R,Fröhlich M,Heining C,Braun S,Spohr C,Iconomou M,Hollek V,Röring M,Horak P,Kreutzfeldt S,Warsow G,Hutter B,Uhrig S,Neumann O,Reuss D,Heiland DH,von Kalle C,Weichert W,Stenzinger A,Brors B,Gli

    更新日期:2020-01-01 00:00:00

  • The chicken Pdcd4 gene is regulated by v-Myb.

    abstract::The retroviral oncogene v-myb encodes a transcription factor (v-Myb) which is responsible for the ability of avian myeloblastosis virus (AMV) to transform myelomonocytic cells. v-Myb is thought to disrupt the differentiation of myelomonocytic cells by affecting the expression of specific target genes. To identify such...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204071

    authors: Schlichter U,Burk O,Worpenberg S,Klempnauer KH

    更新日期:2001-01-11 00:00:00

  • Cyclin D1 integrates G9a-mediated histone methylation.

    abstract::Lysine methylation of histones and non-histone substrates by the SET domain containing protein lysine methyltransferase (KMT) G9a/EHMT2 governs transcription contributing to apoptosis, aberrant cell growth, and pluripotency. The positioning of chromosomes within the nuclear three-dimensional space involves interaction...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0723-8

    authors: Li Z,Jiao X,Di Sante G,Ertel A,Casimiro MC,Wang M,Katiyar S,Ju X,Klopfenstein DV,Tozeren A,Dampier W,Chepelev I,Jeltsch A,Pestell RG

    更新日期:2019-05-01 00:00:00

  • Phorbol esters inhibit fibroblast growth factor-2-stimulated fibroblast proliferation by a p38 MAP kinase dependent pathway.

    abstract::Treatment of fibroblasts with the phorbol ester, 12-O-tetradecanoyl phorbol 13-acetate (TPA), specifically inhibits fibroblast growth factor-2 (FGF-2) induced proliferation. TPA treatment has little or no effect on FGF receptor activation but specifically inhibits the activation of p38 MAPK but not other downstream si...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205268

    authors: Maher P

    更新日期:2002-03-27 00:00:00

  • ACTL6A suppresses p21Cip1 expression to enhance the epidermal squamous cell carcinoma phenotype.

    abstract::Epidermal squamous cell carcinoma (SCC) is a common and highly invasive form of cancer. SCC arises due to ultraviolet light exposure and is associated with increased expression of pro-cancer genes and reduced expression of cancer suppressors. Actin-Like Protein 6A (ACTL6A, BAF53a) is an important protein subunit of th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1371-8

    authors: Shrestha S,Adhikary G,Xu W,Kandasamy S,Eckert RL

    更新日期:2020-09-01 00:00:00

  • Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription.

    abstract::Recent advances in the field of in vitro chromatin assembly have led to in vitro transcription systems which reproduce in the test tube, in vivo characteristics of ligand-dependent transcriptional activation by nuclear receptors. Dissection of these systems has begun to provide us with information concerning the under...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204329

    authors: Dilworth FJ,Chambon P

    更新日期:2001-05-28 00:00:00

  • Gene structure of the human MET proto-oncogene.

    abstract::By direct sequencing of cosmids using primers designed from the known cDNA sequence, we identified 19 exons in the human MET proto-oncogene, and sequenced the corresponding 5' and 3' exon-intron junctions. By homology search in the database of the Washington University Genome Sequence Center (GSC), we identified one a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201338

    authors: Duh FM,Scherer SW,Tsui LC,Lerman MI,Zbar B,Schmidt L

    更新日期:1997-09-25 00:00:00

  • rsc: a novel oncogene with structural and functional homology with the gene family of exchange factors for Ral.

    abstract::A novel oncogene, rsc (rabbit squamous cell carcinoma), has been identified from a DMBA-induced rabbit squamous cell carcinoma using gene transfer and the nude mouse tumorigenesis assay. A full-length cDNA has been isolated and sequenced. rsc has potent tumorigenic activity in nude mice (latency <4 weeks), but does no...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200950

    authors: D'Adamo DR,Novick S,Kahn JM,Leonardi P,Pellicer A

    更新日期:1997-03-20 00:00:00

  • MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.

    abstract::One of the hallmarks of malignancy is the polarization of tumor-associated macrophages (TAMs) from a pro-immune (M1-like) phenotype to an immune-suppressive (M2-like) phenotype. However, the molecular basis of the process is still unclear. MicroRNA (miRNA) comprises a group of small, non-coding RNAs that are broadly e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.258

    authors: Yang J,Zhang Z,Chen C,Liu Y,Si Q,Chuang TH,Li N,Gomez-Cabrero A,Reisfeld RA,Xiang R,Luo Y

    更新日期:2014-06-05 00:00:00

  • Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice.

    abstract::To investigate the tumorigenic potential of mutant p53 when selectively expressed in lung tissue, a transgenic mouse model was developed in which a mutant form of p53 (p53-273H) was placed under the transcriptional control of the lung-specific human surfactant protein C (SP-C) promoter. Two founder mice were identifie...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205909

    authors: Duan W,Ding H,Subler MA,Zhu WG,Zhang H,Stoner GD,Windle JJ,Otterson GA,Villalona-Calero MA

    更新日期:2002-11-07 00:00:00

  • A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma.

    abstract::Abnormalities of the p53 tumour suppressor gene occur in many types of cancer including approximately 60% of colorectal carcinomas. This study investigates in 47 colorectal carcinomas the relationship between stabilised p53 protein detected by immunocytochemistry (ICC), and p53 mutation. 27 cases stained positively wi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Cripps KJ,Purdie CA,Carder PJ,White S,Komine K,Bird CC,Wyllie AH

    更新日期:1994-09-01 00:00:00

  • Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.

    abstract::The mouse pancreatic amylase Amy-2.2 gene was fused to the structural gene for SV40 T antigen, and 51 independent transgenic founder mice carrying the fusion gene were generated. The majority of the founders and 100% of their offspring in the derived transgenic lines developed pancreatic acinar cell carcinomas and sto...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ceci JD,Kovatch RM,Swing DA,Jones JM,Snow CM,Rosenberg MP,Jenkins NA,Copeland NG,Meisler MH

    更新日期:1991-02-01 00:00:00